Resources
About Us
Home Report
Store
DNA Sequencing Market
DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User - Global Forecast to 2031
Report ID:MRHC - 1041309 Pages: 325 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe DNA Sequencing Market was valued at $9.14 billion in 2023. This market is expected to reach $21.30 billion by 2031, from an estimated $9.78 billion in 2024, at a CAGR of 11.8% during the forecast period 2024-2031.
DNA Sequencing Market Size & Forecast
Key factors driving the growth of this market include decreasing sequencing costs, rising incidence of cancer and genetic disorders, the increasing utilization of DNA sequencing in precision medicine, rising R&D investments by pharmaceutical companies, favorable regulatory & reimbursement frameworks, increase in healthcare spending, technological advances in sequencing technologies, and government initiatives aimed at promoting the use of sequencing technology.
Moreover, the growing use of DNA sequencing, favorable government initiatives for large-scale genomic projects, increasing awareness & adoption of targeted therapies, and untapped markets in emerging economies are expected to offer significant opportunities for market growth.
DNA Sequencing Market Growth Drivers
Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research
Cancer is a major cause of death and a prominent obstacle in improving life expectancy in every country around the world. According to GLOBOCAN, the number of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 million in 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million in 2030. Thus, the increasing prevalence of cancer is expected to boost the adoption of NGS in clinical settings. DNA sequencing is considerably contributing to researchers’ understanding of cancer biology. Genomics research supported by NGS has identified genetic heterogeneity even among cancer types that were earlier considered identical. The discovery of unique molecular signatures is helping in the development of potential cancer treatments, increasing the demand for NGS in cancer research.
Click here to: Get Free Sample Pages of this Report
Technological Advancements in Sequencing Products
The demand for next-generation sequencing (NGS) grows has increased the need for managing large volumes of genomic data. The vast amount of data generated by NGS places significant pressure on healthcare providers to effectively analyze, interpret, report, and manage this information. Efficient data storage and computing tools help reduce costs and save time while scaling production and ensuring data security through rigorous monitoring and compliance. These tools also facilitate the sharing of large datasets among multiple teams with specific user access controls.
Technological advancements in NGS informatics solutions have streamlined the process of creating long sequencing runs, analyzing data, monitoring run status, and obtaining results more rapidly. Furthermore, data flow from sequencing instruments can be processed using advanced software, enhancing the management and analysis of genomic data through specialized applications. These advancements have led to the discovery of genetically targeted drugs, early cancer detection through blood tests, and diagnoses for rare diseases. Thus, ongoing advances in sequencing technology are expected to significantly drive the growth of the DNA sequencing market.
DNA Sequencing Market Opportunity
Increasing Application of DNA Sequencing
Precision medicine is an innovative approach to patient care that tailors treatments based on an individual's genetic profile, including genetic alterations caused by disease and lifestyle factors. This method takes into account genetic variability, environmental influences, and personal lifestyle differences among patients. By minimizing reliance on trial-and-error approaches in treatment, precision medicine helps physicians navigate diagnostic challenges and develop strategies tailored to specific patient demographics. Additionally, it offers a comprehensive view of a patient's health and enhances clinical workflows by enabling predictive and preventive care through targeted therapies. Thus, the use of DNA sequencing in precision medicine is anticipated to significantly drive the growth of the DNA sequencing market.
Rising Awareness & Adoption of Targeted Therapies
Targeted DNA sequencing focuses on specific regions of the genome, offering advantages over whole genome sequencing in terms of cost, time efficiency, and data analysis. While whole genome sequencing typically covers target regions at 30x-50x per genome, targeted sequencing achieves much higher coverage at 500x-1000x per genome. This increased coverage allows researchers to identify rare variants more effectively, which would otherwise be more costly to detect using whole genome sequencing methods.
One of the most common applications of targeted sequencing is the detection and validation of single nucleotide polymorphisms (SNPs). Accurate SNP detection and validation are crucial for distinguishing true SNPs from false positives, making targeted sequencing a valuable tool in genome analysis. The benefits of targeted sequencing and its growing adoption are expected to contribute to the growth of the DNA sequencing market.
DNA Sequencing Market Analysis: Key Findings
By Offering: In 2024, the Consumables Segment to Dominate the DNA Sequencing Market
Based on offering, the DNA sequencing market is segmented into consumables, instruments, software, and services. The consumables segment is further sub-segmented into sample preparation kits & reagents and other kits & reagents. In 2024, the consumables segment is anticipated to hold the major share of 73.4% of the DNA sequencing market. This segment’s significant market share is attributed to the recurring demand for consumables, increasing DNA sequencing-based clinical and research applications, and growing preference for sequencing-based diagnostics.
By Application: In 2024, the Research & Other Applications Segment to Dominate the DNA Sequencing Market
Based on application, the market is segmented into research & other applications and clinical applications. In 2024, the research & other applications segment is anticipated to hold the major share of 67.2% of the DNA sequencing market. This segment’s significant market share is attributed to the rising prevalence of genetic disorders, the growing adoption of sequencing-based tests by laboratories, the increasing demand for personalized medicine, and a surge in NGS-based research.
By End User: In 2024, the Pharmaceutical & Biotechnology Companies Segment to Dominate the DNA Sequencing Market
Based on end user, the DNA sequencing market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and other end users. In 2024, the pharmaceutical and biotechnology companies segment is anticipated to hold the major share of 44.7% of the DNA sequencing market. This segment’s significant market share is attributed to the increasing R&D spending by pharmaceutical & biotechnology companies and the rising incidence of chronic diseases, which drive the adoption of DNA sequencing solutions among pharmaceutical & biotechnology companies.
Geographical Analysis
In 2024, North America is anticipated to hold the major share of 49.0% of the DNA sequencing market. North America’s significant market share can be attributed to several factors: increased R&D spending in the pharmaceutical & biotechnology sector, the presence of prominent DNA sequencing solution providers, supportive government initiatives for genomics research, the rising applications of sequencing technologies, heightened awareness of NGS-based diagnostic tests, a rising rate of cancer and genetic disorders, and a favorable reimbursement landscape in the region.
However, the market in Asia-Pacific is slated to register the highest growth rate of 12.9% during the forecast period. Countries such as China and India are anticipated to provide significant opportunities for companies operating in this market. Many Asia-Pacific nations are prioritizing advancements in their healthcare systems, leading to increased investments in healthcare accessibility, infrastructure improvements, and drug discovery initiatives. Additionally, the rising incidence of cancer, the growing adoption of advanced diagnostic and therapeutic technologies, and government initiatives aimed at supporting genome sequencing programs contribute to the growth of this regional market.
DNA Sequencing Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years. The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China).
DNA Sequencing Market Overview: Latest Developments from Key Industry Players
-
In January 2024, Illumina Inc. (U.S.) signed an agreement with Janssen Research & Development, LLC (U.S.) to launch a novel molecular residual disease (MRD) assay. This whole-genome sequencing (WGS) solution is designed for multi-cancer research and aims to detect circular tumor DNA (ctDNA) to better understand disease recurrence or persistence after clinical intervention.
-
In March 2024, Thermo Fisher Scientific Inc. (U.S.) collaborated with Bayer AG (Germany) to develop NGS-based companion diagnostic assays (CDx). These assays are designed to offer decentralized genomic testing with rapid turnaround times, thereby improving patient access to Bayer’s precision cancer therapies.
- In September 2023, Thermo Fisher Scientific Inc. (U.S.) partnered with Pfizer Inc. (U.S.) to expand access to localized NGS-based testing of breast and lung cancer patients in over 30 countries across Africa, Latin America, the Middle East, and Asia, where advanced genomic testing has previously been unavailable or limited.
- In December 2022, Illumina, Inc. signed an agreement with Harvard Pilgrim Health Care to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members from January 2021, leveraging WGS for faster diagnoses of genetic diseases in children.
DNA Sequencing Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
325 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
11.8% |
|
Estimated Market Size (Value) |
$21.30 billion by 2031 |
|
Segments Covered |
By Offering
By Technology
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
|
Key Companies |
The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China). |
Key questions answered in the DNA sequencing market report:
The global DNA sequencing market report includes a qualitative analysis and market sizing for various market segments, including offering, technology, application, and end user. This report involves the analysis of various segments of the DNA sequencing market at the regional and country levels. The report also provides insights on factors impacting market growth, regulatory analysis, pricing analysis, and Porter’s five forces analysis.
The global DNA sequencing market is projected to reach $21.30 billion by 2031 at a CAGR of 11.8% from 2024 to 2031.
Among the offerings, the consumables segment is anticipated to hold the largest share of the DNA sequencing market in 2024.
Among the applications, the research & other applications segment is anticipated to hold the largest share of the DNA sequencing market in 2024.
The growth of this market is driven by several factors: a decline in sequencing costs, a surge in cancer and genetic disorder cases, an increase in the usage of DNA sequencing in diagnostics & precision medicine, a rise in pharmaceutical R&D investments, favorable regulatory & reimbursement policies, an increase in healthcare expenditure, advancements in sequencing technologies, and government policies aimed at promoting genomics research.
Moreover, the expanding scope of DNA sequencing applications, government support for extensive genomic projects, rising adoption of targeted therapies, and untapped potential in emerging nations are expected to offer opportunities for market participants.
The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China).
Emerging economies like China and India are projected to offer significant growth opportunities for market vendors. Rapid economic growth and increased government focus on enhancing the healthcare sector in these countries have resulted in substantial investments aimed at improving healthcare accessibility, upgrading infrastructure, and supporting drug discovery and genome mapping initiatives.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Pricing Analysis
4.4. Industry Trends
4.4.1. Emerging DNA Sequencing Companies’ Focus on Improving Technologies and Reducing Costs
4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
4.4.1.2. Ultima Genomics, Inc. (U.S.)
4.4.1.3. Element Biosciences (U.S.)
4.4.2. Key Market Players’ Emphasis on PorTable and Real-Time Sequencing Technologies
4.5. Regulatory Analysis
4.5.1. North America
4.5.1.1. U.S.
4.5.1.2. Canada
4.5.2. Europe
4.5.3. Asia-Pacific
4.5.3.1. China
4.5.3.2. Japan
4.5.3.3. India
4.5.4. Latin America
4.5.5. Middle East
4.6. Porter’s Five Forces Analysis
5. DNA Sequencing Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Kits & Reagents
5.2.1.1. Library Preparation
5.2.1.2. DNA Extraction & Amplification
5.2.1.3. Quality Control
5.2.1.4. Other Kits & Reagents
5.2.2. Other Consumables
5.3. Instruments
5.4. Software
5.5. Services
6. DNA Sequencing Market Assessment—by Technology
6.1. Overview
6.2. Next-generation Sequencing
6.2.1. Sequencing by Synthesis
6.2.2. Ion Semiconductor Sequencing
6.2.3. Single-molecule Real-Time Sequencing
6.2.4. DNA Nanoball Sequencing
6.2.5. Other NGS Sequencing Technologies
6.3. Sanger Sequencing & Pyrosequencing
7. DNA Sequencing Market Assessment—by Application
7.1. Overview
7.2. Research & Other Applications
7.2.1. Drug Discovery
7.2.2. Agricultural & Animal Research
7.2.3. Other Applications
7.3. Clinical Applications
7.3.1. Oncology
7.3.2. Reproductive Health
7.3.3. Infectious Diseases
7.3.4. Other Clinical Applications
8. DNA Sequencing Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Diagnostic Laboratories
8.4. Academic & Research Institutes
8.5. Other End Users
9. DNA Sequencing Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (ROE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (ROAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (ROLATAM)
9.6. Middle East & Africa (MEA)
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis (2023)
10.5.1. Illumina, Inc. (U.S.)
10.5.2. Thermo Fisher Scientific Inc. (U.S.)
10.5.3. MGI Tech Co., Ltd. (China)
10.5.4. Agilent Technologies, Inc. (U.S.)
10.5.5. QIAGEN N.V. (Netherlands)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
11.1. Illumina, Inc. (U.S.)
11.2. Thermo Fisher Scientific Inc.
11.3. QIAGEN N.V.
11.4. Agilent Technologies, Inc.
11.5. MGI Tech Co., Ltd.
11.6. F. Hoffmann-La Roche Ltd
11.7. Revvity, Inc.
11.8. Pacific Biosciences of California Inc.
11.9. Danaher Corporation
11.10. Bio-Rad Laboratories, Inc.
11.11. Oxford Nanopore Technologies Plc.
11.12. Other Companies
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Number of New Cancer Cases, by Type, 2022 VS. 2040
Table 2 Common Genetic Disorders: Rates of Occurrence
Table 3 Major Genome Sequencing Projects, by Country
Table 4 Health Expenditure, by Country
Table 5 DNA Sequencing Kits & Reagents: Pricing
Table 6 DNA Sequencing Instruments: Product Description & Pricing
Table 7 G4 Specifications
Table 8 UG 100 Specifications
Table 9 AVITI Specifications
Table 10 Regulatory Authorities Governing In Vitro Diagnostics, by Country/REGION
Table 11 Global DNA Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 12 Global DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 13 Global DNA Sequencing Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 15 Global Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
Table 16 Global Library Preparation Market, by Country/Region, 2022-2031 (USD Million)
Table 17 Global DNA Extraction & Amplification Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
Table 19 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
Table 20 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
Table 21 Some of the Companies offering NGS Instruments for DNA Sequencing Are As Follows:
Table 22 Global DNA Sequencing Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Key Players Offering DNA Sequencing Software
Table 24 Global DNA Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
Table 25 Key Players Offering Instrument-related Services
Table 26 Global DNA Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
Table 27 Global DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 28 Global NGS-Based Market, by Technology, 2022–2031 (USD Million)
Table 29 Global NGS Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Sequencing by Synthesis Market for NGS, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Ion Semiconductor Sequencing Market for NGS, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Single-Molecule Real-Time (SMRT) Sequencing Market for NGS, by Country/Region, 2022–2031 (USD Million)
Table 33 Global DNA Nanoball Sequencing Market for NGS, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Other NGS Sequencing Technologies Market, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Sanger Sequencing & Pyrosequencing Market for DNA Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 36 Global DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 37 Global DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 38 Global DNA Sequencing Market for Research & Other Applications, By Country/Region, 2022–2031 (USD Million)
Table 39 Global DNA Sequencing Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 40 Global DNA Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022–2031 (USD Million)
Table 41 Global DNA Sequencing Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 42 GLOBAL DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 43 GLOBAL DNA Sequencing Market for Clinical Applications, by COUNTRY/Region, 2022–2031 (USD Million)
Table 44 Global DNA Sequencing Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 45 Global DNA Sequencing Market for Reproductive Health, by Country/Region, 2022–2031 (USD Million)
Table 46 HIV Prevalence among Adults, by REGION (2020 VS. 2022) (In Million)
Table 47 Global DNA Sequencing Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 48 Global DNA Sequencing Market for Other Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 49 Global DNA Sequencing Market, By End User, 2022–2031 (USD Million)
Table 50 Pharmaceutical Spending in Major Countries
Table 51 GLOBAL DNA Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 52 GLOBAL DNA Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 53 Global DNA Sequencing Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 54 Global DNA Sequencing Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 55 Global DNA Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 56 North America: DNA Sequencing Market, by Country, 2022–2031 (USD Million)
Table 57 North America: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 58 North America: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 59 North America: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 60 North America: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 61 North America: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 62 North America: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 63 North America: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 64 North America: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 65 North America: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 66 U.S.: Key Macroindicators & Microindicators
Table 67 U.S.: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 68 U.S.: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 69 U.S.: Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 70 U.S.: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 71 U.S.: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 72 U.S.: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 73 U.S.: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 74 U.S.: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 75 U.S.: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 76 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments and Genome Canada Contributions, Are As Follows:
Table 77 Canada: Key Macroindicators & Microindicators
Table 78 Canada: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 79 Canada: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 80 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 81 Canada: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 82 Canada: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 83 Canada: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 84 Canada: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 85 Canada: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 86 Canada: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 87 Europe: DNA Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 88 Europe: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 89 Europe: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 90 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 91 Europe: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 92 Europe: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 93 Europe: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 94 Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 95 Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 96 Europe: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 97 Germany: Key Macroindicators & Microindicators
Table 98 Germany: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 99 Germany: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 100 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 101 Germany: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 102 Germany: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 103 Germany: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 104 Germany: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 105 Germany: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 106 Germany: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 107 France: Key Macroindicators & Microindicators
Table 108 France: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 109 France: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 110 France: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 111 France: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 112 France: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 113 France: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 114 France: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 115 France: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 116 France: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 117 U.K.: Key Macroindicators & Microindicators
Table 118 U.K.: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 119 U.K.: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 120 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 121 U.K.: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 122 U.K.: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 123 U.K.: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 124 U.K.: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 125 U.K.: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 126 U.K.: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 127 Italy: Key Macroindicators & Microindicators
Table 128 Italy: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 129 Italy: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 130 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 131 Italy: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 132 Italy: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 133 Italy: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 134 Italy: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 135 Italy: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 136 Italy: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 137 Spain: Key Macroindicators & Microindicators
Table 138 Spain: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 139 Spain: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 140 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 141 Spain: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 142 Spain: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 143 Spain: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 144 Spain: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 145 Spain: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 146 Spain: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 147 Number of Sequences In Each Phase and Other Related Sequencing Information:
Table 148 ROE: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
Table 149 Rest of Europe: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 150 Rest of Europe: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 151 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 152 Rest of Europe: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 153 Rest of Europe: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 154 Rest of Europe: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 155 Rest of Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 156 Rest of Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 157 Rest of Europe: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 158 Asia-Pacific: DNA Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 159 Asia-Pacific: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 160 Asia-Pacific: DNA Sequencing Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 161 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 162 Asia-Pacific: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 163 Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 164 Asia-Pacific: DNA Sequencing Market, by APPLICATION, 2022–2031 (USD Million)
Table 165 Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 166 Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 167 Asia-Pacific: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 168 China: Key Macroindicators & Microindicators
Table 169 China: DNA Sequencing Market, by Offering, 2022–2031 (USD Million)
Table 170 China: DNA Sequencing Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 171 China: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 172 China: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 173 China: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 174 China: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 175 China: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 176 China: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 177 China: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 178 Japan: Key Macroindicators & Microindicators
Table 179 Japan: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 180 Japan: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 181 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 182 Japan: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 183 Japan: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 184 Japan: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 185 Japan: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 186 Japan: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 187 Japan: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 188 INDIA: Key Macroindicators & Microindicators
Table 189 India: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 190 India: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 191 India: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 192 India: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 193 India: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 194 India: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 195 India: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 196 India: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 197 India: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 198 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
Table 199 Rest of Asia-Pacific: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 200 Rest of Asia-Pacific: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 201 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 202 Rest of Asia-Pacific: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 203 Rest of Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 204 Rest of Asia-Pacific: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 205 Rest of Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 206 Rest of Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 207 Rest of Asia-Pacific: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 208 Latin America: DNA Sequencing Market, by Country/Region, 2022–2031 (USD Million)
Table 209 Latin America: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 210 Latin America: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 211 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 212 Latin America: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 213 Latin America: NGS-based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 214 Latin America: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 215 Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 216 Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 217 Latin America: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 218 Brazil: Key Macroindicators & Microindicators
Table 219 Brazil: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 220 Brazil: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 221 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 222 Brazil: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 223 Brazil: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 224 Brazil: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 225 Brazil: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 226 Brazil: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 227 Brazil: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 228 Mexico: Key Macroindicators & Microindicators
Table 229 Mexico: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 230 Mexico: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 231 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 232 Mexico: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 233 Mexico: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 234 Mexico: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 235 Mexico: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 236 Mexico: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 237 Mexico: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 238 Rest of Latin America: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 239 Rest of Latin America: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 240 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 241 Rest of Latin America: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 242 Rest of Latin America: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 243 Rest of Latin America: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 244 Rest of Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 245 Rest of Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 246 Rest of Latin America: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 247 Middle East & Africa: DNA Sequencing Market, by offering, 2022–2031 (USD Million)
Table 248 Middle East & Africa: DNA Sequencing Consumables Market, by Type, 2022–2031 (USD Million)
Table 249 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022–2031 (USD Million)
Table 250 Middle East & Africa: DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 251 Middle East & Africa: NGS-Based DNA Sequencing Market, by Technology, 2022–2031 (USD Million)
Table 252 Middle East & Africa: DNA Sequencing Market, by Application, 2022–2031 (USD Million)
Table 253 Middle East & Africa: DNA Sequencing Market for Research & Other Applications, by Type, 2022–2031 (USD Million)
Table 254 Middle East & Africa: DNA Sequencing Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 255 Middle East & Africa: DNA Sequencing Market, by End User, 2022–2031 (USD Million)
Table 256 Recent Developments, by Company (2021-2024)
Table 257 Some of the Other Companies Operating in the DNA Sequencing Market
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global DNA Sequencing Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 8 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 9 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
Figure 10 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
Figure 11 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 12 Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024–2031)
Figure 13 Share Of Cancer Cases, By Region, 2022 vs. 2040 (%)
Figure 14 Genome Sequencing Costs, 2010–2021 (USD/GENOME)
Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, and China, 2010 VS. 2020 VS. 2021 (USD Million)
Figure 16 Global Pharmaceutical R&D Expenditure, 2014–2028 (USD Billion)
Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
Figure 18 USFDA Regulatory Pathways for IVD Kits
Figure 19 EU Regulatory Pathway - IVDR 2017/746
Figure 20 China: Medical Device Classification and Premarket Requirements FOR IVD Products
Figure 21 Porter's Five Forces Analysis
Figure 22 Global DNA Sequencing Market, by offering, 2022 VS. 2031 (USD Million)
Figure 23 Steps of Sample Preparation in A Typical Next-Generation DNA Sequencing Workflow
Figure 24 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
Figure 25 Steps of DNB Sequencing Technology Include
Figure 26 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
Figure 27 U.S.: New Molecular Entity (NME) APPROVALS
Figure 28 Estimated Number of New Cancer Cases (Million)
Figure 29 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
Figure 30 Global Pharmaceutical R&D Spending, 2014–2028 (USD BILLION)
Figure 31 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 32 North America: DNA Sequencing Market Snapshot
Figure 33 U.S.: Pharmaceutical R&D Expenditure, 2014–2022 (USD Billion)
Figure 34 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
Figure 35 Research Funding Supported by The Canadian Genomics Enterprise, 2022–2023 (%)
Figure 36 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
Figure 37 Europe: Pharmaceutical Industry R&D Expenditure, 2000–2022 (USD Million)
Figure 38 Europe: DNA Sequencing Market Snapshot
Figure 39 Italy: Number of Biotechnology Firms, 2014-2022
Figure 40 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
Figure 41 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
Figure 42 Asia-Pacific: DNA Sequencing Market Snapshot
Figure 43 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
Figure 44 Japan: Number of New Molecular Entities Approved, 2014-2022
Figure 45 Latin America: DNA Sequencing Market Snapshot
Figure 46 Key Growth Strategies Adopted by Leading Players, 2021–2024
Figure 47 DNA Sequencing Market: Competitive Benchmarking by offering
Figure 48 DNA Sequencing Market: Competitive Benchmarking, by Region
Figure 49 Competitive Dashboard: DNA Sequencing Market
Figure 50 Global DNA Sequencing Market Share Analysis, by Key Players, 2023 (%)
Figure 51 Illumina, Inc.: Financial SNAPSHOT (2023)
Figure 52 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 53 QIAGEN N.V: Financial Snapshot (2023)
Figure 54 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 55 MGI Tech Co., Ltd.: Financial Snapshot (2023)
Figure 56 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
Figure 57 Revvity, Inc.: Financial Snapshot (2023)
Figure 58 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
Figure 59 Danaher Corporation: Financial Snapshot (2023)
Figure 60 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Whole Genome Sequencing Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Oct-2024
VNA and PACS Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Mar-2024
Sequencing Kits Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
